Nanotechnology and cancer

K. Meena Kumari, M. C. Satish Kumar, B. R. Eesha, Amberkar Mohanbabu Vittalrao, K. L. Bairy, A. L. Udupa

Research output: Contribution to journalArticle

Abstract

Clinical medicine has seen tremendous improvements during past several decades. Despite its progress in many illnesses till date, cancer is not detected at the earliest subclinical stages. Patients still are exposed to highly toxic whole body chemotherapy. However with the discovery of nanotechnology which has emerged as a new tool for early diagnosis and as a targeted drug delivery system to the cancer cells will prevent mortality and increase the quality of life in cancer patients. Though extensive research is being done for various diseases like autoimmune, inflammatory and metabolic disorders, in this review we have stressed on the usage of various nanotechnological tools and methods in cancer detection and treatment. However like any novel technology, this also has some safety and ethical issues which have been discussed in this review.

Original languageEnglish
Pages (from-to)267-276
Number of pages10
JournalPharmacologyonline
Volume2
Publication statusPublished - 01-01-2010

Fingerprint

Nanotechnology
Neoplasms
Poisons
Clinical Medicine
Metabolic Diseases
Drug Delivery Systems
Ethics
Autoimmune Diseases
Early Diagnosis
Quality of Life
Technology
Safety
Drug Therapy
Mortality
Research
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Cite this

Meena Kumari, K., Satish Kumar, M. C., Eesha, B. R., Vittalrao, A. M., Bairy, K. L., & Udupa, A. L. (2010). Nanotechnology and cancer. Pharmacologyonline, 2, 267-276.
Meena Kumari, K. ; Satish Kumar, M. C. ; Eesha, B. R. ; Vittalrao, Amberkar Mohanbabu ; Bairy, K. L. ; Udupa, A. L. / Nanotechnology and cancer. In: Pharmacologyonline. 2010 ; Vol. 2. pp. 267-276.
@article{bae86553b29d411cac6468bc420488c2,
title = "Nanotechnology and cancer",
abstract = "Clinical medicine has seen tremendous improvements during past several decades. Despite its progress in many illnesses till date, cancer is not detected at the earliest subclinical stages. Patients still are exposed to highly toxic whole body chemotherapy. However with the discovery of nanotechnology which has emerged as a new tool for early diagnosis and as a targeted drug delivery system to the cancer cells will prevent mortality and increase the quality of life in cancer patients. Though extensive research is being done for various diseases like autoimmune, inflammatory and metabolic disorders, in this review we have stressed on the usage of various nanotechnological tools and methods in cancer detection and treatment. However like any novel technology, this also has some safety and ethical issues which have been discussed in this review.",
author = "{Meena Kumari}, K. and {Satish Kumar}, {M. C.} and Eesha, {B. R.} and Vittalrao, {Amberkar Mohanbabu} and Bairy, {K. L.} and Udupa, {A. L.}",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "2",
pages = "267--276",
journal = "Pharmacologyonline",
issn = "1827-8620",
publisher = "SILAE (Italo-Latin American Society of Ethnomedicine)",

}

Meena Kumari, K, Satish Kumar, MC, Eesha, BR, Vittalrao, AM, Bairy, KL & Udupa, AL 2010, 'Nanotechnology and cancer', Pharmacologyonline, vol. 2, pp. 267-276.

Nanotechnology and cancer. / Meena Kumari, K.; Satish Kumar, M. C.; Eesha, B. R.; Vittalrao, Amberkar Mohanbabu; Bairy, K. L.; Udupa, A. L.

In: Pharmacologyonline, Vol. 2, 01.01.2010, p. 267-276.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nanotechnology and cancer

AU - Meena Kumari, K.

AU - Satish Kumar, M. C.

AU - Eesha, B. R.

AU - Vittalrao, Amberkar Mohanbabu

AU - Bairy, K. L.

AU - Udupa, A. L.

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Clinical medicine has seen tremendous improvements during past several decades. Despite its progress in many illnesses till date, cancer is not detected at the earliest subclinical stages. Patients still are exposed to highly toxic whole body chemotherapy. However with the discovery of nanotechnology which has emerged as a new tool for early diagnosis and as a targeted drug delivery system to the cancer cells will prevent mortality and increase the quality of life in cancer patients. Though extensive research is being done for various diseases like autoimmune, inflammatory and metabolic disorders, in this review we have stressed on the usage of various nanotechnological tools and methods in cancer detection and treatment. However like any novel technology, this also has some safety and ethical issues which have been discussed in this review.

AB - Clinical medicine has seen tremendous improvements during past several decades. Despite its progress in many illnesses till date, cancer is not detected at the earliest subclinical stages. Patients still are exposed to highly toxic whole body chemotherapy. However with the discovery of nanotechnology which has emerged as a new tool for early diagnosis and as a targeted drug delivery system to the cancer cells will prevent mortality and increase the quality of life in cancer patients. Though extensive research is being done for various diseases like autoimmune, inflammatory and metabolic disorders, in this review we have stressed on the usage of various nanotechnological tools and methods in cancer detection and treatment. However like any novel technology, this also has some safety and ethical issues which have been discussed in this review.

UR - http://www.scopus.com/inward/record.url?scp=85011918234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011918234&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 267

EP - 276

JO - Pharmacologyonline

JF - Pharmacologyonline

SN - 1827-8620

ER -

Meena Kumari K, Satish Kumar MC, Eesha BR, Vittalrao AM, Bairy KL, Udupa AL. Nanotechnology and cancer. Pharmacologyonline. 2010 Jan 1;2:267-276.